Zhejiang Wecome Pharmaceutical Company Limited
SZSE:300878.SZ
23.26 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -144.878 | -8.039 | 45.12 | 96.547 | 135.704 | 126.013 | 87.777 | 95.158 | 80.851 | 50.024 | 18.775 | 14.383 |
| Depreciation & Amortization
| 68.075 | 49.246 | 43.492 | 26.99 | 12.169 | 11.89 | 11.005 | 10.144 | 0 | 5.201 | 4.285 | 4.011 |
| Deferred Income Tax
| 0 | 0 | 7.694 | -17.552 | 0.67 | -0.179 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 35.848 | 34.294 | 51.697 | -204.686 | -117.404 | -34.69 | -2.965 | -83.84 | 0 | -25.958 | 21.941 | 5.806 |
| Accounts Receivables
| 72.919 | 67.534 | 38.152 | -151.672 | -122.428 | -53.363 | 0 | 0 | 0 | -15.191 | 1.05 | 4.919 |
| Inventory
| -7.147 | -37.603 | -3.127 | -45.619 | -21.847 | 12.809 | 1.312 | -27.167 | 0 | -20.641 | -3.107 | 0.992 |
| Accounts Payables
| 0 | 20.437 | 8.979 | 10.158 | 26.201 | 6.044 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -29.923 | -16.073 | 7.694 | -17.552 | 0.67 | -0.179 | -4.276 | -56.673 | 0 | -5.317 | 25.048 | 4.814 |
| Other Non Cash Items
| 13.783 | -17.212 | 6.258 | 13.404 | 12.342 | 9.549 | 9.756 | 7.542 | 19.303 | 0.366 | 1.009 | 1.782 |
| Operating Cash Flow
| -27.173 | 58.289 | 146.568 | -67.744 | 42.812 | 112.762 | 105.573 | 29.004 | 100.155 | 29.633 | 46.01 | 25.982 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -126.923 | -139.285 | -248.443 | -171.097 | -152.339 | -114.976 | -172.729 | -42.04 | -47.966 | -38.483 | -40.679 | -11.475 |
| Acquisitions Net
| 37.316 | 0 | -9.791 | -18.578 | 0.029 | 0 | 0 | 0.008 | 0 | 0 | 0.642 | 0 |
| Purchases Of Investments
| 0 | -242.77 | -25 | -2.905 | -19.964 | 0 | 0 | 0 | 0 | 0 | -3.431 | 0 |
| Sales Maturities Of Investments
| 247.757 | 2.205 | 19.843 | 0 | -0.029 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 30.14 | 389.164 | -180.429 | 0.231 | 0.029 | -6 | 0 | 6.008 | 0.426 | 2.348 | 6.43 | 4.238 |
| Investing Cash Flow
| 188.29 | 9.313 | -443.82 | -192.35 | -172.274 | -120.976 | -172.729 | -36.033 | -47.54 | -36.134 | -37.037 | -7.237 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -127.937 | 117.037 | 224.782 | 21.347 | -151.179 | 94.744 | 42.635 | 28.5 | 0 | 0 | -18 | -12 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -44.4 | -7.016 | -43.437 | -80.439 | -7.833 | -5.727 | -1.422 | -0.018 | -0.133 | 0 | -0.881 | -1.512 |
| Other Financing Activities
| -61.754 | -12.449 | -2.604 | 5.129 | 727.907 | -1.796 | -0.969 | -8.076 | -0.6 | -1.63 | 30.03 | 1.6 |
| Financing Cash Flow
| -234.09 | 97.572 | 178.741 | -53.963 | 568.895 | 87.221 | 40.244 | 20.406 | -0.733 | -1.63 | 11.149 | -11.912 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0.026 | 0 | 0.001 | 0 |
| Net Change In Cash
| -72.973 | 165.175 | -118.511 | -314.057 | 439.433 | 79.007 | -26.912 | 13.377 | 51.908 | -8.132 | 20.124 | 6.833 |
| Cash At End Of Period
| 253.609 | 326.582 | 161.408 | 279.919 | 593.976 | 154.543 | 75.536 | 102.448 | 89.071 | 37.164 | 45.295 | 25.171 |